Hypereosinophilic syndrome accompanied by buerger's disease-like femoral arterial occlusions

Internal Medicine

Volumn 46, Issue 23, 2007, Pages 1919-1922

  Kawata, Eri ^a,b,c   Kuroda, Junya ^d   Wada, Katsuya ^a   Yoshida, Makie ^a   Kamiuchi, Kenji ^a   Nakayama Harusato, Ichiko ^a   Kimura, Shinya ^c   Maekawa, Taira ^c   Kitagawa, Yoshihiro ^a  

^a Osaka Railway Hospital   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Arterial occlusion; Corticosteroid; Hypereosinophilia; Vessel intervention

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; C REACTIVE PROTEIN; CORTICOSTEROID; D DIMER; FIBRINOGEN DEGRADATION PRODUCT; IMMUNOGLOBULIN E; INTERLEUKIN 5; METHYLPREDNISOLONE; PARACETAMOL; SOLUBLE INTERLEUKIN 2 RECEPTOR; UROKINASE; VASODILATOR AGENT;

ADULT; ARTERY OCCLUSION; ARTICLE; BUERGER DISEASE; CASE REPORT; CLAUDICATION; DIFFERENTIAL DIAGNOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; FEMORAL ARTERY; FEVER; HUMAN; HYPEREOSINOPHILIA; HYPEREOSINOPHILIC SYNDROME; LEG DISEASE; LEUKOCYTOSIS; LIVER DYSFUNCTION; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PNEUMONIA; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; THROMBOCYTOPENIA;

ADULT; ANGIOGRAPHY; ANGIOPLASTY, BALLOON; ANTICOAGULANTS; ARTERIAL OCCLUSIVE DISEASES; FEMORAL ARTERY; HUMANS; HYPEREOSINOPHILIC SYNDROME; MALE;

EID: 37549048585     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.0371     Document Type: Article

References (26)

1. Bain B, Pierre R, Imbert M, Vardiman JW, Brunning RD, Flandrin G. Chronic eosinophilic leukaemia and the hypereosinophilic syndrome. In: World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Jaffe ES, Harris NL, Stein H, Vardiman JW, Eds. IARC Press, Lyon, 2001: 29-31.
2. Hardy WR, Anderson RE. The hypereosinophilic syndromes. Ann Intern Med 68: 1220-1229, 1968.
3. Chusid MF, Dale DC, West BC, Wolff SM. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 54: 1-27, 1975.
4. Fauci AS, Harley JB, Roberts WC, Ferrans J, Gralnick HR, Bjornson BH. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med 97: 78-92, 1982.
5. Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood 83: 2759-2779, 1994.
6. Roufosse F, Bartholome E, Schandene L, Goldman M, Cogan E. The idiopathic hypereosinophilic syndrome: clinical presentation, pathogenesis and therapeutic strategies. Drugs of Today 34: 361-373, 1998.
7. Roufosse F, Cogan E, Goldman M. The hypereosinophilic syndrome revisited. Annu Rev Med 54: 169-184, 2003.
8. Wilkins HJ, Crane MM, Copeland K, Williams WV. Hypereosinophilic syndrome: An update. Am J Hematol 80: 148-157, 2005.
9. Gleich GJ, Leiferman KM. The hypereosinophilic syndromes: still more heterogeneity. Curr Opin Immunol 17: 679-684, 2005.
10. Spry CJF, Davies J, Thi PC, Olsen EGJ, Oakley CM, Goodwin JF. Clinical features of fifteen patients with the hypereosinophilic syndrome. Q J Med 52: 1-22, 1983.
11. Nagashima T, Kamimura T, Nara H, Iwamoto M, Okazaki H, Minota S. Kimura's disease presenting as steroid-responsive thromboangiitis obliterans. Circulation 114: 10-11, 2006.
12. Funahashi S, Masaki I, Furuyama T. Hypereosinophilic syndrome accompanying gangrene of the toes with peripheral arterial occlusion. A case report. Angiology 57: 231-234, 2006.
13. Kim SH, Kim TB, Yun Y, et al. Hypereosinophilia presenting as eosinophilic vasculitis and multiple peripheral artery occlusions without organ involvement. J Korean Med Sci 20: 677-679, 2005.
14. Ponsky TA, Brody F, Giordano J, Garcia R, Kardon D, Schwartz A. Brachial artery occlusion secondary to hypereosinophilic syndrome. J Vasc Surg 42: 796-799, 2005.
15. Matsunaga R, Soma Y, Watabe H, et al. Thromboangiitis obliterans associated with peripheral blood eosinophilia and eosinophilic cellultis-like skin lesions. Int J Dermatol 44: 615-617, 2005.
16. Naito AT, Minamino T, Tateno K, Nagai T, Komuro I. Steroid-responsive thromboangiitis obliterans. Lancet 364: 1098, 2004.
17. Stephan D, Lipsker D, Sens P, Hassani S, Welsch M. Hypereosinophilia-induced digital necrosis in a smoking patient. Int Angiol 22: 95-97, 2003.
18. Grosshans E, Asch PH. Eosinophilic arteritis of the scalp. Ann Dermatol Venereol 128: 545-548, 2001 (in French, Abstract in English).
19. Oppliger R, Gay-Crosier F, Dayer E, Hauser C. Digital necrosis in a patient with hypereosinophilic syndrome in the absence of cutaneous eosinophilic vasculitis. Br J Dermatol 144: 1087-1090, 2001.
20. Sawai T, Uzuki M, Shibata Y, et al. Hypereosinophilic syndrome accompanying eosinophilic vasculitis. Myakkangaku 42: 193-197, 2002 (in Japanese).
21. Fujimoto M, Sato S, Hayashi N, Wakugawa N, Tsuchida T, Tamaki K. Juvenile temporal arteritis with eosinophilia: a distinct clinicopathological entity. Dermatology 192: 32-35, 1996.
22. Song YW, Kim HA, Song KY. Eosinophilic fasciitis with occlusive vasculitis and gangrene of the finger. J Rheumatol 22: 356-359, 1995.
23. Ferguson GT, Starkebaum G. Thromboangiitis obliterans associated with idiopathic hypereosinophilia. Arch Intern Med 145: 1726-1728, 1985.
24. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M. Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86: 1327-1330, 2001.
25. Watts R, Lane S, Hanslik T, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66: 222-227, 2007.
26. Wardlaw AJ. Eosinophils in the 1990s: new perspectives on their role in health and disease. Postgrad Med J 70: 536-552, 1994.